Efficacy of once-yearly zoledronic acid 5 mg in men with osteoporosis with different levels of serum total testosterone; Reginster, Jean-Yves ; et alin Osteoporosis International (2012, March), 23(S2), 79-80 Detailed reference viewed: 32 (2 ULg) Effets d'une perfusion unique d'acide zolédronique 5 mg versus risédronate (5 mg/jour) sur le remodelage osseux sur 1 an chez des patients avec ostéroporose cortisonique; ; et al in Revue du Rhumatisme (2008), 75 Detailed reference viewed: 8 (2 ULg) Effect of 5-year risedronate therapy on fracture reduction and bone histology and histomorphometry; ; et al in Arthritis and Rheumatism (2001), 44(1220), 256 Detailed reference viewed: 7 (0 ULg) |
||